People Background Check
Find People:

Gary A Truitt, Age 78133 Thatcher Ct, Shepherdstown, WV 25443

Get Report
Known as:
Gary Dr Truitt Gary A Trutt Theresa Truitt
Related to:
Sheryl Martin 77

Gary Truitt Phones & Addresses

Shepherdstown, WV

Passaic, NJ

507 Pate St, Apex, NC 27502 (919) 387-7334

Media, PA

109 Garner Ave, Bloomfield, NJ 07003 (973) 893-1193

Marysville, CA

133 Thatcher Ct, Shepherdstown, WV 25443 (201) 406-7589

Show more

Work

Position: Service Occupations

Education

Degree: Graduate or professional degree

Mentions for Gary A Truitt

Career records & work history

Lawyers & Attorneys

Gary Truitt Photo 1

Gary Truitt - Lawyer

Office:
Highmark Inc.
ISLN:
911277355
Admitted:
1975
University:
Robert Morris College, M.S., 1983; University of Pittsburgh, B.A., 1972
Law School:
Duquesne University, J.D., 1975

Publications & IP owners

Us Patents

Compounds, Process And Intermediates

US Patent:
5110958, May 5, 1992
Filed:
May 6, 1991
Appl. No.:
7/698176
Inventors:
Enrico G. Baggiolini - North Caldwell NJ
Andrew D. Batcho - North Caldwell NJ
Gary A. Truitt - Passaic NJ
Milan R. Uskokovic - Upper Montclair NJ
Peter M. Wovkulich - Nutley NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07D31726
US Classification:
549454
Abstract:
The claimed invention relates to intermediate compounds of the formula ##STR1## wherein R is hydrogen or methyl, R. sub. 1 and R. sub. 2 each, independently, is hydrogen, lower alkyl or aryl, or taken together are lower alkylene of from 3 to 6 carbon atoms, and the dotted (. . . ) line is an optional bond.

Trihydroxy-Cholecacliferol And Trihydroxy-Ergocalciferol For Treating Leukemia

US Patent:
5120722, Jun 9, 1992
Filed:
Mar 19, 1990
Appl. No.:
7/495519
Inventors:
Enrico G. Baggiolini - North Caldwell NJ
Andrew D. Batcho - North Caldwell NJ
Gary A. Truitt - Passaic NJ
Milan R. Uskokovic - Upper Montclair NJ
Peter M. Wovkulich - Nutley NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 3159
C07J 900
US Classification:
514167
Abstract:
The compounds 1. alpha. ,25(S), 26-trihydroxy-. DELTA. sup. 22 -cholecalciferol; 1. alpha. ,25(R), 26-trihydroxy-. DELTA. sup. 22 -cholecalciferol; 1. alpha. ,25(S),26-trihydroxyergocalciferol, 1. alpha. ,25(R),26-trihydroxyergocalciferol and pharmaceutical compositions comprising the compounds as well as methods of making and using these compounds are disclosed.

Trifluorinated-1.Alpha.,25S-Dihydroxy Vitamin D3 Compounds

US Patent:
5039671, Aug 13, 1991
Filed:
Nov 16, 1989
Appl. No.:
7/438547
Inventors:
Enrico G. Baggiolini - North Caldwell NJ
Giacomo Pizzolato - Glen Ridge NJ
Gary A. Truitt - Bloomfield NJ
Milan R. Uskokovic - Upper Montclair NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A01N 4500
C07J17200
US Classification:
514167
Abstract:
26, 26, 26-Trifluoro-1. alpha. , 25-dihydroxy-cholecalciferol, and the 25R or 25S epimer thereof, are described, as well as processes and intermediates utilized to prepare the same, as well as pharmaceutical compositions containing the same. 26,26,26-trifluoro 1. alpha. , 25-dihydroxycholecalciferol and the 25R or 25S epimer thereof are useful agents in the treatment of disease states such as osteoporosis, oseodystrophy and leukemia.

Vitamin D3 Analogs

US Patent:
5145846, Sep 8, 1992
Filed:
Apr 10, 1991
Appl. No.:
7/683389
Inventors:
Enrico G. Baggiolini - late of North Caldwell NJ
Bernard M. Hennessy - Nutley NJ
Gary A. Truitt - Bloomfield NJ
Milan R. Uskokovic - Upper Montclair NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A01N 4500
C07J17200
US Classification:
514167
Abstract:
Compounds of the formula ##STR1## wherein R is hydrogen or hydroxy, R. sub. 5 is hydrogen, and A is ##STR2## with the proviso that when A is --C. tbd. C--, R. sub. 5 may also be deuterium, are described. The compounds of formula I are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the treatment of neoplastic diseases such as leukemia, and as agents for the treatment of sebaceous gland diseases such as acne or seborrheic dermatitis.

25,26-Dehydro-1.Alpha.,24R-Dihydroxycholecalciferol And 25,26-Dehydro-1.Alpha.,24S-Dihydroxycholecalciferol And The Epimeric Mixture

US Patent:
4594340, Jun 10, 1986
Filed:
Nov 29, 1984
Appl. No.:
6/676121
Inventors:
John J. Partridge - Upper Montclair NJ
Gary A. Truitt - Passaic NJ
Milan R. Uskokovic - Upper Montclair NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07J 900
US Classification:
514167
Abstract:
The syntheses of 25,26-dehydro-1. alpha. ,24R-dihydroxycholecalciferol and 25,26-dehydro-1. alpha. ,24S-dihydroxycholecalciferol and the epimeric mixture which are useful as differentiation inducing agent and anti-proliferation agents are described. 25,26-dehydro-1. alpha. ,24R-dihydroxycholecalciferol, 25,26-dehydro-1. alpha. ,24S-dihydroxycholecalciferol, and the epimeric mixture are useful in treating osteoporosis, tumors and leukemia.

Novel Trifluorinated Vitamin D3 Intermediates

US Patent:
4906785, Mar 6, 1990
Filed:
Jan 22, 1986
Appl. No.:
6/821299
Inventors:
Enrico G. Baggiolini - North Caldwell NJ
Giacomo Pizzolato - Glen Ridge NJ
Gary A. Truitt - Bloomfield NJ
Milan R. Uskovic - Upper Montclair NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07C14700
C07C 49105
US Classification:
568 33
Abstract:
26,26,26-Trifluoro-1. alpha. ,25-dihydroxy-cholecalciferol, and the 25R or 25S epimer thereof, are described, as well as processes and intermediates utilized to prepare the same, as well as pharmaceutical compositions containing the same. 26,26,26-trifluoro 1. alpha. ,25-dihydroxycholecalciferol and the 25R or 25S epimer thereof are useful agents in the treatment of disease states such as osteoporosis, osteodystrophy and leukemia.

Vitamin D.sub.3 Analogs

US Patent:
5087619, Feb 11, 1992
Filed:
Mar 23, 1990
Appl. No.:
7/498062
Inventors:
Enrico G. Baggiolini - late of North Caldwell NJ
Barbara J. Baggiolini - North Caldwell NJ
Bernard M. Hennessy - Nutley NJ
Gary A. Truitt - Bloomfield NJ
Milan R. Uskokovic - Upper Montclair NJ
Assignee:
Hoffman-La Roche Inc. - Nutley NJ
International Classification:
A01N 4500
C07J17200
C07J17500
C07F 704
US Classification:
514167
Abstract:
Compounds of the formula ##STR1## wherein R is hydrogen or hydroxy, R. sub. 5 is hydrogen, and A is --C. tbd. C--, ##STR2## or --CH. sub. 2 --CH. sub. 2 --, with the proviso that when A is --C. tbd. C--, R. sub. 5 may also be deuterium, are described. The compounds of formula I are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the treatment of neoplastic diseases such as leukemia, and as agents for the treatment of sebaceous gland diseases such as acne or seborrheic dermatitis.

Immunosuppressive Agents

US Patent:
4749710, Jun 7, 1988
Filed:
May 1, 1985
Appl. No.:
6/729326
Inventors:
Gary A. Truitt - Bloomfield NJ
William R. Benjamin - Cedar Grove NJ
Bruce H. Devens - Glen Rock NJ
Maurice K. Gately - Montville NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 3159
US Classification:
514167
Abstract:
The invention relates to pharmaceutical compositions comprising at least one Vitamin D derivative and a method of using the pharmaceutical compositions in suppressing immune responses.

Isbn (Books And Publications)

Painting Indiana Ii: The Changing Face Of Agriculture

Author:
Gary R. Truitt
ISBN #:
0253348196

Possible Relatives

David A Truitt  Dean M Truitt  Deborah B Truitt  Dan Truitt  Daniel L Truitt  Aaron H Truitt  Darrell Truitt  Gary W Stamps  Gary S Standley  Gary L Stanfill 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.